TOP

Research Article

Split Viewer

Mol. Cells 2010; 30(4): 341-345

Published online September 10, 2010

https://doi.org/10.1007/s10059-010-0124-x

© The Korean Society for Molecular and Cellular Biology

Visfatin Stimulates Proliferation of MCF-7 Human Breast Cancer Cells

Jae Geun Kim1,2, Eun Ok Kim1, Bo Ra Jeong1, Young Joo Min2,4, Jeong Woo Park1,2, Eun Sook Kim3, Il Seong Namgoong3, Young Il Kim3, and Byung Ju Lee1,*

1Department of Biological Sciences, College of Natural Sciences, University of Ulsan, Ulsan 680-749, Korea, 2Biomedical Research Center, College of Medicine, University of Ulsan, Ulsan 682-714, Korea, 3Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 682-714, Korea, 4Division of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 682-714, Korea

Correspondence to : *Correspondence: bjlee@ulsan.ac.kr

Received: March 29, 2010; Revised: July 7, 2010; Accepted: July 9, 2010

Abstract

Obesity, a condition characterized by increased fat con-tent and altered secretion of adipokines, is a risk factor for postmenopausal breast cancer. Visfatin has recently been established as a novel adipokine that is highly enriched in visceral fat. Here we report that visfatin regulated proliferation of MCF-7 human breast cancer cells. Exogenous administration of recombinant visfatin increased cell proliferation and DNA synthesis rate in MCF-7 cells. Furthermore, visfatin activated G1-S phase cell cycle progression by upregulation of cyclin D1 and cdk2 expression. Visfatin also increased the expression of matrix metalloproteinases 2, matrix metalloproteinases 9, and vascular endothelial growth factor genes, suggesting that it may function in metastasis and angiogenesis of breast cancer. Taken together, these findings suggest that visfatin plays an important role in breast cancer progression.

Keywords angiogenesis, breast cancer, metastasis, proliferation, visfatin

Article

Research Article

Mol. Cells 2010; 30(4): 341-345

Published online October 31, 2010 https://doi.org/10.1007/s10059-010-0124-x

Copyright © The Korean Society for Molecular and Cellular Biology.

Visfatin Stimulates Proliferation of MCF-7 Human Breast Cancer Cells

Jae Geun Kim1,2, Eun Ok Kim1, Bo Ra Jeong1, Young Joo Min2,4, Jeong Woo Park1,2, Eun Sook Kim3, Il Seong Namgoong3, Young Il Kim3, and Byung Ju Lee1,*

1Department of Biological Sciences, College of Natural Sciences, University of Ulsan, Ulsan 680-749, Korea, 2Biomedical Research Center, College of Medicine, University of Ulsan, Ulsan 682-714, Korea, 3Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 682-714, Korea, 4Division of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 682-714, Korea

Correspondence to:*Correspondence: bjlee@ulsan.ac.kr

Received: March 29, 2010; Revised: July 7, 2010; Accepted: July 9, 2010

Abstract

Obesity, a condition characterized by increased fat con-tent and altered secretion of adipokines, is a risk factor for postmenopausal breast cancer. Visfatin has recently been established as a novel adipokine that is highly enriched in visceral fat. Here we report that visfatin regulated proliferation of MCF-7 human breast cancer cells. Exogenous administration of recombinant visfatin increased cell proliferation and DNA synthesis rate in MCF-7 cells. Furthermore, visfatin activated G1-S phase cell cycle progression by upregulation of cyclin D1 and cdk2 expression. Visfatin also increased the expression of matrix metalloproteinases 2, matrix metalloproteinases 9, and vascular endothelial growth factor genes, suggesting that it may function in metastasis and angiogenesis of breast cancer. Taken together, these findings suggest that visfatin plays an important role in breast cancer progression.

Keywords: angiogenesis, breast cancer, metastasis, proliferation, visfatin

Mol. Cells
Nov 30, 2023 Vol.46 No.11, pp. 655~725
COVER PICTURE
Kim et al. (pp. 710-724) demonstrated that a pathogen-derived Ralstonia pseudosolanacearum type III effector RipL delays flowering time and enhances susceptibility to bacterial infection in Arabidopsis thaliana. Shown is the RipL-expressing Arabidopsis plant, which displays general dampening of the transcriptional program during pathogen infection, grown in long-day conditions.

Supplementary File

Share this article on

  • line

Related articles in Mol. Cells

Molecules and Cells

eISSN 0219-1032
qr-code Download